CAS 59721-29-8 appears in our catalog under these names: Camostat Mesylate, Camostat Mesylate, >95% (HPLC), Camostat mesylate/ 99.69% (existing batch purity), Camostat Mesilate, Camostat methanesulfate, 98% . Offered by: Chemat Brand, TRC, TargetMol, GLPBio, Thermo Scientific (Alfa Aesar). Available pack sizes: on request, 10mg, 1g, 2,5g, 25mg, 50mg, 100mg, 200mg.
Camostat mesylate is a methanesulfonate (mesylate) salt prepared from equimolar amounts of camostat and methanesulfonic acid. It is a serine protease inhibitor approved and marketed in Japan in 1985 for the alleviation of acute symptoms associated with chronic pancreatitis. In 1994, it was approved for the treatment of postoperative reflux esophagitis. It has a role as an anticoronaviral agent, an antiviral agent, an antineoplastic agent, an antihypertensive agent, an antifibrinolytic drug, a serine protease inhibitor and an anti-inflammatory agent. It contains a camostat(1+).
Source: ChEBI
| Molecular formula | C21H26N4O8S |
|---|---|
| Molecular weight | 494.5 g/mol |
| IUPAC name | [4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate;methanesulfonic acid |
| InChIKey | FSEKIHNIDBATFG-UHFFFAOYSA-N |
| SMILES | CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N.CS(=O)(=O)O |
Computed by PubChem (NCBI)